The Valley Fever Collaborative, a University of Arizona Health Sciences-led partnership with Arizona State University and Northern Arizona University, was awarded $3.1 million in Regents’ Grant funding by the Arizona Board of Regents to start an integrated, statewide research project to identify, characterize and map hotspots and routes of exposure for Valley fever.

Researchers in the Comprehensive Pain and Addiction Center are seeking new therapies for migraine in an unlikely place – the endogenous cannabinoid system.

The Arizona Board of Regents voted to confirm the appointments of University of Arizona Health Sciences faculty members Drs. Juanita Merchant and Donata Vercelli as Regents Professors.

If you haven’t received a COVID-19 vaccine yet, now’s the time to join many other of your fellow Arizonans doing so right now.

The Arizona Board of Regents is putting $4.5 million toward Valley fever research over the next three years.

Our Neighbor’s Farm and Pantry will distribute food on April 12 as well as offer free health screenings and information 10 a.m. to noon with support from the University of Arizona Mel and Enid Zuckerman College of Public Health.

COVID-19 is still circulating in the U.S. and Arizona, but one of the last holdout rules for preventing the virus may soon go away: face mask requirements on public transportation, including planes.

The Arizona Board of Regents earmarked $3.3 million to support research into Valley fever detection technology, genomics and seasonal outbreak patterns.

Phoenix will soon be the home of the Center for Advanced Molecular and Immunological Therapies, a new University of Arizona Health Sciences center focused on developing biological therapies that stimulate or suppress the immune system to fight disease.